InvestorsHub Logo

ChrisJP

08/09/17 2:13 PM

#3691 RE: maseraticoupe #3689

Thanks. I knew there had to be an explanation.

Here's this too -- the obvious good news/bad news story:

http://www.marketwatch.com/story/valeant-is-on-track-to-reduce-about-5-billion-of-debt-but-it-has-more-than-27-billion-to-go-2017-08-08?siteid=rss&rss=1

Chris

maseraticoupe

08/09/17 2:20 PM

#3692 RE: maseraticoupe #3689

Mathis said on CNBC that his pps target for VRX is still $10 !

Wells Fargo may be manipulating the stock via unwarranted negativity and shorting to attain his pps target so he looks smart.

conix

08/10/17 7:35 PM

#3698 RE: maseraticoupe #3689

Valeant Pharma (VRX) Holder John Paulson Sold Almost 1M Shares



In an amended 13D filing on Valeant Pharma (NYSE: VRX), John Paulson's Paulson & Co. disclosed it sold 974,365 shares on 08/09 at $14.66.
The firm continues to own 20,839,035 shares, or 6%.
Paulson & Co said the sales are due to rebalancing of our portfolios based on asset flows and represent approximately 4.5% of the Reporting Person's Common Stock holding.